SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹7.92 Cr | ₹-5.20 Cr | ₹3.17 Cr | ₹7.99 Cr | ₹0.54 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹7.92 Cr |
| Mar2024 | ₹-5.20 Cr |
| Mar2023 | ₹3.17 Cr |
| Mar2022 | ₹7.99 Cr |
| Mar2021 | ₹0.54 Cr |
How is Cash Flow from Operating Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.92 Cr | Positive | |
| Mar2024 | ₹-5.20 Cr | Negative | |
| Mar2023 | ₹3.17 Cr | -60.32 | |
| Mar2022 | ₹7.99 Cr | 1,387.71 | |
| Mar2021 | ₹0.54 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,483.7 Cr | 14.6% | 5.9% | 130.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 14.6% |
5.9% |
130.1% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses